145 related articles for article (PubMed ID: 28977999)
1. Platelet-derived growth factor-C promotes human melanoma aggressiveness through activation of neuropilin-1.
Ruffini F; Levati L; Graziani G; Caporali S; Atzori MG; D'Atri S; Lacal PM
Oncotarget; 2017 Sep; 8(40):66833-66848. PubMed ID: 28977999
[TBL] [Abstract][Full Text] [Related]
2. Placenta growth factor and neuropilin-1 collaborate in promoting melanoma aggressiveness.
Pagani E; Ruffini F; Antonini Cappellini GC; Scoppola A; Fortes C; Marchetti P; Graziani G; D'Atri S; Lacal PM
Int J Oncol; 2016 Apr; 48(4):1581-9. PubMed ID: 26846845
[TBL] [Abstract][Full Text] [Related]
3. Targeting of PDGF-C/NRP-1 autocrine loop as a new strategy for counteracting the invasiveness of melanoma resistant to braf inhibitors.
Ruffini F; Ceci C; Atzori MG; Caporali S; Levati L; Bonmassar L; Cappellini GCA; D'Atri S; Graziani G; Lacal PM
Pharmacol Res; 2023 Jun; 192():106782. PubMed ID: 37127213
[TBL] [Abstract][Full Text] [Related]
4. Cilengitide downmodulates invasiveness and vasculogenic mimicry of neuropilin 1 expressing melanoma cells through the inhibition of αvβ5 integrin.
Ruffini F; Graziani G; Levati L; Tentori L; D'Atri S; Lacal PM
Int J Cancer; 2015 Mar; 136(6):E545-58. PubMed ID: 25284767
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological inhibition of PDGF-C/neuropilin-1 interaction: A novel strategy to reduce melanoma metastatic potential.
Ceci C; Ruffini F; Falconi M; Grazia Atzori M; Falzon A; Lozzi F; Iacovelli F; D'Atri S; Graziani G; Miguel Lacal P
Biomed Pharmacother; 2024 May; 176():116766. PubMed ID: 38788599
[TBL] [Abstract][Full Text] [Related]
6. Neuropilin-1 expression promotes invasiveness of melanoma cells through vascular endothelial growth factor receptor-2-dependent and -independent mechanisms.
Ruffini F; D'Atri S; Lacal PM
Int J Oncol; 2013 Jul; 43(1):297-306. PubMed ID: 23685409
[TBL] [Abstract][Full Text] [Related]
7. Platelet-derived growth factor C and calpain-3 are modulators of human melanoma cell invasiveness.
Ruffini F; Tentori L; Dorio AS; Arcelli D; D'Amati G; D'Atri S; Graziani G; Lacal PM
Oncol Rep; 2013 Dec; 30(6):2887-96. PubMed ID: 24126726
[TBL] [Abstract][Full Text] [Related]
8. Neuropilin-1 as Therapeutic Target for Malignant Melanoma.
Graziani G; Lacal PM
Front Oncol; 2015; 5():125. PubMed ID: 26090340
[TBL] [Abstract][Full Text] [Related]
9. Role of NRP-1 in VEGF-VEGFR2-Independent Tumorigenesis.
Hu C; Jiang X
Target Oncol; 2016 Aug; 11(4):501-5. PubMed ID: 26916409
[TBL] [Abstract][Full Text] [Related]
10. An autocrine loop directed by the vascular endothelial growth factor promotes invasiveness of human melanoma cells.
Lacal PM; Ruffini F; Pagani E; D'Atri S
Int J Oncol; 2005 Dec; 27(6):1625-32. PubMed ID: 16273219
[TBL] [Abstract][Full Text] [Related]
11. Platelet-derived growth factor receptors form complexes with neuropilin-1 during megakaryocytic differentiation of thrombopoietin-dependent UT-7/TPO cells.
Ohsaka A; Hirota-Komatsu S; Araki M; Komatsu N
Biochem Biophys Res Commun; 2015 Apr; 459(3):443-9. PubMed ID: 25744030
[TBL] [Abstract][Full Text] [Related]
12. VEGF/NRP-1axis promotes progression of breast cancer via enhancement of epithelial-mesenchymal transition and activation of NF-κB and β-catenin.
Luo M; Hou L; Li J; Shao S; Huang S; Meng D; Liu L; Feng L; Xia P; Qin T; Zhao X
Cancer Lett; 2016 Apr; 373(1):1-11. PubMed ID: 26805761
[TBL] [Abstract][Full Text] [Related]
13. Relative effects of VEGF-A and VEGF-C on endothelial cell proliferation, migration and PAF synthesis: Role of neuropilin-1.
Bernatchez PN; Rollin S; Soker S; Sirois MG
J Cell Biochem; 2002; 85(3):629-39. PubMed ID: 11968003
[TBL] [Abstract][Full Text] [Related]
14. Platelet-derived growth factor C promotes revascularization in ischemic limbs of diabetic mice.
Moriya J; Wu X; Zavala-Solorio J; Ross J; Liang XH; Ferrara N
J Vasc Surg; 2014 May; 59(5):1402-9.e1-4. PubMed ID: 23856609
[TBL] [Abstract][Full Text] [Related]
15. Expression and regulation of the novel vascular endothelial growth factor receptor neuropilin-1 by epidermal growth factor in human pancreatic carcinoma.
Parikh AA; Liu WB; Fan F; Stoeltzing O; Reinmuth N; Bruns CJ; Bucana CD; Evans DB; Ellis LM
Cancer; 2003 Aug; 98(4):720-9. PubMed ID: 12910515
[TBL] [Abstract][Full Text] [Related]
16. Neuropilin-1 suppresses tumorigenic properties in a human pancreatic adenocarcinoma cell line lacking neuropilin-1 coreceptors.
Gray MJ; Wey JS; Belcheva A; McCarty MF; Trevino JG; Evans DB; Ellis LM; Gallick GE
Cancer Res; 2005 May; 65(9):3664-70. PubMed ID: 15867361
[TBL] [Abstract][Full Text] [Related]
17. Expression of the vascular endothelial growth factor receptor neuropilin-1 in the human endometrium.
Hess AP; Schanz A; Baston-Buest DM; Hirchenhain J; Stoff-Khalili MA; Bielfeld P; Kruessel JS
J Reprod Immunol; 2009 Jan; 79(2):129-36. PubMed ID: 18996601
[TBL] [Abstract][Full Text] [Related]
18. Platelet-derived growth factor activates porcine thecal cell phosphatidylinositol-3-kinase-Akt/PKB and ras-extracellular signal-regulated kinase-1/2 kinase signaling pathways via the platelet-derived growth factor-beta receptor.
Taylor CC
Endocrinology; 2000 Apr; 141(4):1545-53. PubMed ID: 10746662
[TBL] [Abstract][Full Text] [Related]
19. Neuropilin-1 (NRP-1) and Magnetic Nanoparticles, a Potential Combination for Diagnosis and Therapy of Gliomas.
Chen L; Zhang G; Shi Y; Qiu R; Khan AA
Curr Pharm Des; 2015; 21(37):5434-49. PubMed ID: 26377659
[TBL] [Abstract][Full Text] [Related]
20. Extracellular signal-regulated kinases and AP-1 mediate the up-regulation of vascular endothelial growth factor by PDGF in human vascular smooth muscle cells.
Chang HJ; Park JS; Kim MH; Hong MH; Kim KM; Kim SM; Shin BA; Ahn BW; Jung YD
Int J Oncol; 2006 Jan; 28(1):135-41. PubMed ID: 16327989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
